AR and Familial prostate cancer: Recent insights into genome alterations in prostate cancer that impact signaling pathways beyond the androgen receptor axis, subtypes of early stage and advanced PCa, and the dynamics of tumor-promoting and tumor-suppressive effects of immune cells are revealing new approaches to disease intervention.